Ailazzat Aitkenova | Medicine Development | Best Research Article Award

Best Research Article Award

Ailazzat Aitkenova
Karaganda Medical University, Kazakhstan
Ailazzat Aitkenova
Affiliation Karaganda Medical University
Country Kazakhstan
Scopus ID
58637239800
Documents 2
Citations Citations by 7 documents
h-index 1
Subject Area Medicine Development
Event Computer Scientists Awards
ORCID
0000-0002-0851-866X

Ailazzat Aitkenova is an academic researcher affiliated with Karaganda Medical University, Kazakhstan, whose scholarly profile reflects emerging contributions to medicine development and interdisciplinary healthcare research. Her academic work includes scientific publications indexed in international databases and participation in scholarly initiatives associated with medical innovation and evidence-based research methodologies. This academic recognition article has been prepared in relation to the Best Research Article Award presented through the Computer Scientists Awards platform.[1]

Abstract

This article presents a scholarly recognition profile of Ailazzat Aitkenova, highlighting her academic contributions, research visibility, and involvement in medicine development studies. The profile evaluates her publication activity, indexed academic presence, and emerging research impact within the context of international scientific recognition frameworks. Emphasis is placed on her participation in evidence-based healthcare research and academic dissemination through indexed scientific publications.[2][3]

Keywords

Medicine Development; Healthcare Research; Academic Recognition; Medical Innovation; Scientific Publications; Evidence-Based Medicine; Research Impact; Scholarly Communication; Clinical Studies; Best Research Article Award.

Introduction

Contemporary academic recognition systems frequently assess researchers based on publication quality, citation indicators, interdisciplinary contributions, and institutional affiliations. Ailazzat Aitkenova’s scholarly profile reflects participation in scientific research activities associated with healthcare and medicine development disciplines.[1]

Research in medicine development contributes significantly to the advancement of healthcare systems, clinical methodologies, and evidence-based treatment frameworks. Academic contributions in this field support scientific communication, institutional collaboration, and innovation within modern medical research environments.[4]

Research Profile

Aitkenova is affiliated with Karaganda Medical University, a recognized institution contributing to healthcare education and medical sciences research in Kazakhstan. Her academic profile includes indexed publications and scholarly engagement in medicine-related research activities.[1]

The available Scopus metrics associated with the researcher indicate citation activity and emerging visibility within the scientific community. Citation data, although modest in scale, reflects the continuing relevance and accessibility of her scholarly contributions within specialized academic contexts.[1]

Her ORCID registration supports transparent scholarly identification and facilitates integration across international academic databases and research information systems.[5]

Research Contributions

The research contributions associated with Dr. Aitkenova are connected to medicine development and healthcare-oriented scientific inquiry. Her scholarly work contributes to the broader understanding of evidence-based approaches and research dissemination within clinical and academic environments.[3]

Academic studies in medicine development frequently involve interdisciplinary methodologies, clinical evaluation processes, and scientific communication standards designed to improve healthcare outcomes and institutional research quality. Such contributions are significant for strengthening research collaboration and knowledge transfer across medical disciplines.[4]

Her indexed publication record demonstrates engagement with international scholarly publishing systems and contributes to the accessibility of research findings within broader scientific networks.[1]

Publications

Ailazzat Aitkenova has contributed to peer-reviewed scientific publications indexed within international research databases. Her publication profile reflects participation in medicine-related scholarly communication and academic dissemination activities.[1]

  • Research publications addressing medicine development methodologies and healthcare research practices.[2]
  • Scientific contributions related to evidence-based clinical and academic research frameworks.[4]
  • Indexed academic works supporting scholarly visibility and interdisciplinary research communication.[3]

Her publication record contributes to the academic representation of medicine development research and reflects participation in internationally recognized indexing systems and scholarly databases.[1]

Research Impact

Research impact within emerging scholarly profiles is commonly evaluated through publication accessibility, citation engagement, and academic dissemination activities. Dr. Aitkenova’s indexed publications and citation metrics indicate ongoing participation within scientific research networks and healthcare-related academic discussions.[1]

The integration of medicine development research with evidence-based methodologies supports improvements in healthcare education, scientific communication, and clinical innovation. Such contributions are relevant within contemporary medical research environments focused on interdisciplinary collaboration and applied healthcare outcomes.[4]

The researcher’s academic visibility is additionally strengthened through standardized researcher identification systems such as ORCID and indexed citation databases that support international scholarly discoverability.[5]

Award Suitability

The academic profile of Dr. Ailazzat Aitkenova demonstrates characteristics commonly evaluated within research recognition frameworks, including indexed publication activity, scientific engagement, and participation in medicine development research initiatives.[1]

Her involvement in scholarly publishing and healthcare-oriented scientific inquiry aligns with the objectives of international academic award programs that emphasize research quality, interdisciplinary collaboration, and evidence-based scientific contribution.[6]

The researcher’s institutional affiliation, publication record, and integration within recognized academic indexing systems collectively support consideration for professional recognition through the Best Research Article Award platform.[6]

Conclusion

Ailazzat Aitkenova represents an emerging academic profile within medicine development and healthcare research. Her scholarly contributions, indexed publication activity, and participation in scientific dissemination demonstrate continued engagement with contemporary medical research frameworks and academic communication systems.[1]

This recognition article highlights the researcher’s academic presence and emphasizes the relevance of evidence-based medicine research within evolving global healthcare environments. Her professional activities align with broader standards associated with scholarly recognition and research excellence initiatives.[4]

References

  1. Elsevier. (n.d.). Scopus author details: Dr. Ailazzat Aitkenova, Author ID 58637239800. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=58637239800
  2. World Health Organization. (2021). Global perspectives on healthcare research and medicine development.
    https://doi.org/10.1016/S0140-6736(21)02648-4
  3. Ioannidis, J. P. A. (2016). The importance of reproducibility in medical and scientific research. PLoS Medicine.
    https://doi.org/10.1371/journal.pmed.1002264
  4. Sackett, D. L., Rosenberg, W. M. C., Gray, J. A. M., Haynes, R. B., & Richardson, W. S. (1996). Evidence based medicine: what it is and what it isn’t. BMJ.
    https://doi.org/10.1136/bmj.312.7023.71
  5. ORCID. (n.d.). ORCID researcher identifier registry.
    https://orcid.org/0000-0002-0851-866X
  6. Computer Scientists Awards. (n.d.). International academic award and conference platform.
    https://computerscientists.net/

Anna Iwan | Medicine | Research Excellence Award

Dr. Anna Iwan | Medicine | Research Excellence Award

University Clinical Hospital No.4 | Poland

Dr. Anna Iwan is a dedicated clinical oncology and internal medicine specialist with a strong focus on patient-centered cancer care, emergency medicine, and interdisciplinary clinical practice. Her professional work reflects continuous advancement in oncology treatment approaches, particularly in gynecological oncology and radiotherapy, combined with a commitment to improving patient outcomes through compassionate care and effective communication. She demonstrates strong teamwork, clinical decision-making, and empathetic patient management. Although primarily focused on clinical practice, her research visibility across Scopus and Google Scholar remains limited, with minimal indexed publications, resulting in currently low citation counts, document records, and an emerging h-index, indicating potential for future academic and research contributions.

View ORCID Profile

Featured Publications

Dr. Anita Rogowicz-Frontczak | Medicine | Research Excellence Award

Dr. Anita Rogowicz-Frontczak | Medicine | Research Excellence Award

Assistant Professor | Poznan University of Medical Science | Poland

Dr. Anita Rogowicz-Frontczak is a clinical researcher specializing in diabetology, endocrinology, and internal medicine, with a strong focus on diabetes, insulin resistance, thyroid disorders, and cardiovascular risk. Her research explores metabolic and autoimmune interactions, particularly in type 1 diabetes and thyroid disease, contributing to improved clinical understanding and patient care strategies. She has authored numerous peer-reviewed publications and educational contributions in metabolic health and clinical nutrition. Her scholarly impact is reflected in Scopus with 484 citations across 26 documents and an h-index of 12, alongside a strong Google Scholar presence, demonstrating sustained research influence and academic contribution.

Citation Metrics (Scopus)

500

400

300

200

100

0

Citations
484

Documents
26

h-index
12

Citations
Documents
h-index


View Scopus Profile View ORCID Profile

Featured Publications

Assist. Prof. Dr. Simona Dedoni | Health Sciences | Research Excellence Award

Assist. Prof. Dr. Simona Dedoni | Health Sciences | Research Excellence Award

Assistant Professor | University of Cagliari | Italy

Assist. Prof. Dr. Simona Dedoni is a researcher specializing in pharmacology, industrial biochemistry, and antiviral drug development, with a strong focus on molecular mechanisms of neurotoxicity and interferon-induced cellular responses. Her work contributes to understanding drug interactions, therapeutic pathways, and biomedical applications in disease treatment. She has established a significant scientific presence through high-impact publications and interdisciplinary research. According to Scopus data, she has 912 citations across 51 documents with an h-index of 19, reflecting strong academic influence, while her Google Scholar profile further indicates sustained citation growth and research visibility in pharmacological and biomedical sciences.

Citation Metrics

1000

800

600

400

200

0

 

Citations
912

Documents
51

h-index
19

                               ■ Citations
Documents
h-index


View Scopus Profile View ORCID Profile

Featured Publications

Prof. Dr. Dachel Martínez Asanza | Medicine | Best Researcher Award

Prof. Dr. Dachel Martínez Asanza | Medicine | Best Researcher Award

Professor/ Senior Researcher | University of Medical Sciences of Havana | Cuba

Prof. Dr. Dachel Martínez Asanza is a distinguished Cuban scholar and senior researcher in the field of dental sciences and medical education, recognized for her interdisciplinary expertise in comprehensive dentistry, health promotion, epidemiology, and pedagogical innovation in medical education. Her academic pursuits bridge clinical dentistry with public health, emphasizing preventive oral care, biopsychosocial health management, and the integration of digital and natural medicine within community health frameworks. A full professor at the University of Medical Sciences of Havana, Dr. Asanza has made substantial contributions to advancing dental education through work-based learning methodologies and curriculum development in health sciences. Her research explores the intersection of technology, digital health, and education, reflecting a deep commitment to enhancing healthcare delivery and educational practices in dentistry. With a Scopus record of 26 indexed publications, over 143 citations from 107 documents, and an h-index of 7, alongside Google Scholar metrics of 371 total citations, an h-index of 11, and an i10-index of 12, Dr. Asanza’s scholarly impact is widely recognized. Her works are featured in reputed international journals, often addressing themes such as digital health adoption, green innovation, and AI applications in healthcare.

Profile

Scopus | ORCID | Google Scholar

Featured Publications

  • Golmankhaneh, A. K., Tunç, S., Schlichtinger, A. M., & Martínez Asanza, D. (2024). Modeling tumor growth using fractal calculus: Insights into tumor dynamics. Biosystems, 235, 105071.

  • Kamel Mouloudj, A. B., Bouarar, A. C., Martínez Asanza, D., & Linda, M. (2023). Factors influencing the adoption of digital health apps: An extended technology acceptance model (TAM). Integrating Digital Health Strategies for Effective Administration, 116–132.

  • Martínez Asanza, D. (2018). Traditional teaching in the 21st century? Neuronum Magazine, 4(1), 99–106.

  • Martínez-Asanza, D. (2021). Regarding work-based learning, a guiding principle of Cuban medical education. FEM: Journal of the Medical Education Foundation, 24(6), 325–325.

  • Njoku, A., Mouloudj, K., Bouarar, A. C., Evans, M. A., & Martínez Asanza, D. (2024). Intentions to create green start-ups for collection of unwanted drugs: An empirical study. Sustainability, 16(7), 2797.

Prof. Wei Wu | Medicine | Best Researcher Award

Prof. Wei Wu | Medicine | Best Researcher Award

Prof. Wei Wu | Director | Guangdong Provincial Institute of Public Health Guangdong Provincial Center for Disease Control and Prevention | China

Dr. Wei Wu is a distinguished public health scientist specializing in labor and environmental hygiene, microbial epidemiology, and health data analytics. His research primarily explores the intersection of gut microbiota, metabolic diseases, and public health, employing advanced population cohort and multi-omics data analysis to uncover novel biomarkers and disease risk genes. Dr. Wu’s studies contribute significantly to understanding nutrient–gut flora–host interactions, guiding innovative therapeutic targets for metabolic and infectious diseases. He has also made substantial contributions to vaccine health economics and hygiene assessment in rail transit systems. As a postgraduate supervisor and active member of multiple national scientific committees, Dr. Wu plays a vital role in shaping public health policy and research in China. His impactful scientific output has earned recognition in leading journals, including Nature Medicine and Microbiome. According to Scopus, he has published 35 documents with over 1,577 citations, an h-index of 13, and his work is widely cited across 1,498 documents. On Google Scholar, his publications have similarly received extensive academic engagement, underscoring his global research influence in environmental and preventive health sciences.

Publication Profile

Scopus | ORCID

Featured Publications

He, Y., Wu, W., Zheng, H. M., Li, P., McDonald, D., Sheng, H. F., et al. (2018). Regional variation limits applications of healthy gut microbiome reference ranges and disease models. Nature Medicine, 24(10), 1532–1535.

He, Y., Wu, W., Wu, S., Zheng, H. M., Li, P., Sheng, H. F., et al. (2018). Linking gut microbiota, metabolic syndrome and economic status based on a population-level analysis. Microbiome, 6(1), 172.

Guo, X., Yan, M., Huang, D., Chen, S., Zhang, D., Li, Z., Yang, X., & Wu, W. (2023). A large scale 16S ribosomal RNA gene amplicon dataset of hand, foot and mouth patients and healthy individuals. Scientific Data, 10(48), 1–6.

Yan, M., Guo, X., Ji, G., Huang, R., Huang, D., Li, Z., Zhang, D., Chen, S., Cao, R., Yang, X., & Wu, W. (2023). Mechanism-based role of the intestinal microbiota in gestational diabetes mellitus: A systematic review and meta-analysis. Frontiers in Immunology, 13(3), 1–13.

Wang, H., Luo, L., & Wu, W. (2023). SAS statistical analysis and applications from introduction to mastery (2nd ed.). Posts & Telecom Press.

Dr. Shao Guang Liu | Medicine | Best Researcher Award

Dr. Shao Guang Liu | Medicine | Best Researcher Award

Dr. Shao Guang Liu | Associate Professor | Gansu Provincial Hospital | China

Dr. Liushaoguang is an accomplished associate professor and clinical expert in trauma and emergency medicine, currently contributing to the advancement of medical research and patient care at Gansu Provincial Hospital. His research primarily focuses on emergency trauma management and sepsis-induced peritonitis, with a strong emphasis on molecular and immunological mechanisms underlying trauma-related complications. Dr. Liushaoguang has led and completed several significant provincial-level projects, including studies on the construction of trauma care system management models and investigations into dendritic cell function transformation and immune paralysis in sepsis. His scholarly contributions reflect a deep integration of clinical insight and biomedical research aimed at improving critical care outcomes. His work has been widely recognized in academic circles, with a citation record of 160 citations across 11 documents and an h-index of 6 on Scopus, demonstrating the impactful nature of his research. On Google Scholar, his publications have also garnered substantial attention from the scientific community. In addition to his research achievements, Dr. Liushaoguang serves on the editorial board of the Chinese Journal of Traumatology, further underscoring his commitment to advancing medical knowledge. His published works explore various aspects of sepsis, endothelial function, gene methylation, and circular RNA mechanisms in inflammatory responses.

Profile

Scopus

Featured Publications

  • Liushaoguang. (2023). Four differentially methylated gene pairs to predict the prognosis for early stage. Frontiers in Genetics.

  • Liushaoguang. (2023). Circular RNA circ_0001105 protects the intestinal barrier of septic rats by inhibiting inflammation. BMC Gastroenterology.

  • Liushaoguang. (2022). Transcriptomics changes in the peritoneum of mice with lipopolysaccharide-induced peritonitis. Scientific Reports.

  • Liushaoguang. (2022). Endothelial progenitor cell-derived exosomal miRNA-31 alleviates septic peritonitis. Cell Death Discovery.

  • Liushaoguang. (2021). Research on the construction of the trauma care system management model in Gansu Province. Chinese Journal of Traumatology.

Dr. Eleni Memi | Medicine | Best Researcher Award

Dr. Eleni Memi | Medicine | Best Researcher Award

Dr. Eleni Memi | Clinician | National and Kapodistrian University of Athens | Greece

Dr. Eleni Memi is a distinguished medical scientist and endocrinologist from Greece whose research focuses on endocrinology, diabetes, metabolism, reproductive endocrinology, and thyroid gland pathophysiology. Her scientific contributions span both clinical and translational aspects of endocrine disorders, with special emphasis on hormonal regulation, metabolic diseases, glycosaminoglycans, and reproductive endocrinology in women. Dr. Memi has made substantial advancements in understanding the interplay between thyroid dysfunction, glucocorticoid activity, and reproductive health, integrating molecular mechanisms with clinical applications. Her work in endocrine-related metabolic disorders has contributed to novel insights into hormonal pathways and disease outcomes. She has authored several influential papers and a book chapter published by Elsevier. Her scholarly impact is reflected in Scopus with 72 citations, 12 documents, and an h-index of 5, while Google Scholar reports 129 citations, an h-index of 6, and an i10-index of 6, underscoring her growing academic influence in medical research.

Publication Profile

Scopus | ORCID | Google Scholar

Featured Publications

  1. Memi, E., Pavli, P., Maria, P., Vrachnis, N., & Mastorakos, G. (2024). Diagnostic and therapeutic use of oral micronized progesterone in endocrinology. Reviews in Endocrine and Metabolic Disorders.

  2. Alexandraki, K. I., Violetis, O., Memi, E., Fryssira, H., Papanikolaou, V., Papagianni, M., & Mastorakos, G. (2025). A rare combination of hypogonadotropic hypogonadism, GH deficiency and rectal atresia in a female with an FGFR1 variant: A case report and systematic review of the literature. Endocrine.

  3. Kanouta, F., Karampitsakos, T., Memi, E., Vrachnis, N., Macut, D., & Mastorakos, G. (2025). Epigenetic effects of endogenous and exogenous glucocorticosteroids during pregnancy on the offspring: A systematic-narrative review. Hormones (Athens).

  4. Pontikides, N., Karras, S., Kaprara, A., Anagnostis, P., Mintziori, G., Goulis, D. G., Memi, E., & Krassas, G. (2014). Genetic basis of familial isolated hyperparathyroidism: A case series and a narrative review of the literature. Journal of Bone and Mineral Metabolism.

  5. Memi, E., Karakiulakis, G., Goma, F., & Papakonstantinou, E. (2012). The functional role of glycosaminoglycans in the pathophysiology of the thyroid gland and their putative role as prognostic, diagnostic and therapeutic agents in thyroid pathologies. Review of Clinical Pharmacology and Pharmacokinetics.

Golnar Rahimzadeh | Medicine | Best Researcher Award

Assist. Prof. Dr. Golnar Rahimzadeh | Medicine | Best Researcher Award

Mazandaran University of Medical Sciences | Iran

Assist. Prof. Dr. Golnar Rahimzadeh is an Iranian researcher and academic specializing in bacteriophage therapy, pediatric infectious diseases, and antimicrobial resistance. She currently serves as an Assistant Professor at the Pediatric Infectious Diseases Research Center, Communicable Diseases Institute, Mazandaran University of Medical Sciences. With a strong scientific foundation in microbiology and biotechnology, she has contributed extensively to developing innovative therapeutic approaches against drug-resistant pathogens. Her work integrates laboratory expertise, clinical research, and translational science, particularly focusing on infectious diseases in children. She is also a pioneer in developing nanotechnology-based phage therapies and advanced biomedical applications.

Publication Profile

Scopus

ORCID

Education Background

She began her academic journey with a Bachelor’s degree at Islamic Azad University in Isfahan, later pursuing a Master’s at the Science and Research Branch of Islamic Azad University in Tehran. Her dedication to microbiology and medical sciences led her to complete a Ph.D. at Mazandaran University of Medical Sciences. She further advanced her expertise through postdoctoral training at the same institution, focusing on innovative therapeutic technologies and bacteriophage applications. This academic pathway shaped her multidisciplinary perspective, combining molecular biology, biotechnology, and infectious diseases research.

Professional Experience

Assist. Prof. Dr. Golnar Rahimzadeh has held diverse professional roles, starting as a clinical and pathological laboratory expert in Isfahan and later contributing at Royan Stem Cell Technology Company in Tehran. She played an instrumental role in the Stem Cell Cord Blood Bank at Sari Birth Cohort Center, specializing in HLA typing and flow cytometry. Her academic career advanced with her appointment as an Assistant Professor at Mazandaran University of Medical Sciences, where she leads projects in infectious disease research. She has also served as a technical assistant in pediatric laboratory settings and has been actively engaged in scientific congresses, contributing to advancing knowledge in her field.

Awards and Honors

Her distinguished achievements include her appointment as an Assistant Professor at Mazandaran University of Medical Sciences, reflecting her academic and research excellence. She has also registered a knowledge-based company, Persian Nano-Bio Therapy, specializing in the isolation and production of industrial bacteriophage strains for pharmaceutical treatments, marking a significant innovation in biotechnology. In addition, she has received recognition for her scientific contributions through participation in national congresses, international conferences, and collaborative research projects. Her innovative patents on phage-based therapies for burn wounds and infectious diseases further highlight her impact in medical biotechnology.

Research Focus

Her primary research interests lie in bacteriophage therapy, antimicrobial resistance, and pediatric infectious diseases. She has made notable contributions in developing phage-based gels, inhaled phage therapies, and nanobioparticles for combating resistant pathogens such as MRSA, Pseudomonas aeruginosa, and Acinetobacter baumannii. She is also actively involved in clinical research on COVID associated infections, nosocomial infections, and secondary bacterial pneumonia. By bridging laboratory innovations with clinical applications, her work emphasizes translational medicine aimed at developing safe, effective, and sustainable treatments against multidrug-resistant microorganisms.

Publication

Antimicrobial activity Kefir on Pseudomonas aeruginosa
Published Year: 2011
Citation: 34

Evaluation of wound healing activities of kefir products
Published Year: 2012
Citation: 97

Characterization of methicillin-resistant Staphylococcus aureus phages from sewage at a pediatric hospital
Published Year: 2016
Citation: 42

Endolysins of Bacteriophages as an Anti-Methicillin Resistant Staphylococcus aureus Infection in Children: A Narrative Review
Published Year: 2018
Citation: 19

Phage Therapy in Treatment of Gram-negative Bacterial Infections: A Systematic Review
Published Year: 2018
Citation: 63

Conclusion

Assist. Prof. Dr. Golnar Rahimzadeh stands as a leading figure in pediatric infectious disease research and phage therapy innovations. Her career reflects a balance of academic scholarship, industrial innovation, and translational medical research. With numerous publications, patents, and international collaborations, she continues to advance the global understanding of antimicrobial resistance and the therapeutic potential of bacteriophages. Her dedication to improving pediatric health through biotechnology has positioned her as an influential voice in the scientific community, making lasting contributions to both academic medicine and applied biomedical sciences.

Jayalakshmi Mariakuttikan | Medicine | Best Researcher Award

Dr. Jayalakshmi Mariakuttikan | Medicine | Best Researcher Award

Dr. Jayalakshmi Mariakuttikan , Associate Professor , Madurai Kamaraj University , India.

Dr. M. Jayalakshmi, Ph.D., is a distinguished Associate Professor and Head of the Department of Immunology at the School of Biological Sciences, Madurai Kamaraj University, Tamil Nadu. Since 2005, she has dedicated her research to immunogenetics, focusing on disease susceptibility in South Indian populations. With postdoctoral training from UCSF, USA, and a prolific academic journey, she has mentored numerous scholars and spearheaded advanced research projects. She has delivered over 110 invited talks, published 40+ international papers, and contributed to impactful policy research. Her commitment to immunology and education underscores her stature as a respected academician and researcher in biomedical science.

Publication Profile

Scopus

Google Scholar

🎓 Education Background

Dr. Jayalakshmi earned her Ph.D. in Immunogenetics from Manonmaniam Sundaranar University, conducting her doctoral research at Holy Cross College, Nagercoil. She ranked first in her B.Sc. and M.Sc. (Zoology) programs from the same university, showcasing academic excellence early on. Her M.Phil. at St. Xavier’s College, Palayamkottai, also saw her secure the top rank. She further enhanced her expertise through a prestigious Raman Postdoctoral Fellowship at the University of California, San Francisco (UCSF), focusing on transplantation immunogenetics. Her strong academic foundation and exposure to global research platforms empower her ongoing scientific contributions in immunogenetics and molecular diagnostics.

🧪 Professional Experience

Dr. M. Jayalakshmi began her career as an Assistant Professor in 2005 at Madurai Kamaraj University and has served as Associate Professor and Head since 2017. Her academic leadership includes coordinating molecular diagnostic training, spearheading RUSA-funded research facilities, and serving as a syndicate member at MKU. She has also mentored numerous M.Sc. and Ph.D. students. With experience spanning teaching, research, and administration, she has organized skill development programs benefiting over 1,100 students. Additionally, she plays key roles in academic boards, ethics committees, and national curriculum development, consistently contributing to life science education and translational biomedical research.

🏅 Awards and Honors

Dr. Jayalakshmi’s academic brilliance has earned her multiple prestigious awards. She was a gold medalist and university topper in both B.Sc. and M.Sc. Zoology programs. She received the National Merit Scholarship and CSIR Fellowships during her Ph.D. journey. Her innovative teaching earned her the Gold Medal from Madurai Kamaraj University. She was awarded the UGC-Raman Postdoctoral Fellowship for her research at UCSF, USA, and has served as a DST-INSPIRE Mentor since 2008. Her scholarly contributions include 16 best paper awards at international conferences, reflecting her impactful presence in global immunogenetics research and scientific communication.

🔬 Research Focus

Dr. Jayalakshmi’s research centers on the immunogenetics of breast cancer, autoimmune disorders (Type 1 Diabetes, RHD), infectious diseases (HIV, HBV), and chronic kidney disease. Since 2005, she has analyzed the South Indian population’s genetic profiles using advanced tools like PCR and Next-Generation Sequencing. Her studies aim to identify genetic susceptibility markers and early diagnostic tools, contributing significantly to personalized medicine. Her lab has also explored microbiomes and HLA allele associations through funded research projects. With over 120 gene sequences and 14 whole-genome submissions to NCBI, her team’s research outcomes have international implications in immunogenomics and translational diagnostics.

🧭 Conclusion

Dr. M. Jayalakshmi exemplifies excellence in education, research, and scientific leadership in immunogenetics. Her pioneering work across cancer, infectious diseases, and autoimmune disorders in South India has advanced diagnostic research and molecular epidemiology. With a global research footprint, numerous scholarly contributions, and unwavering dedication to mentorship and innovation, she continues to inspire students and scientists alike. Through her active role in academic councils and ethical boards, she advocates for responsible science and societal health impact. Her career is a testament to the transformative power of science driven by curiosity, precision, and community engagement.

📚 Top Publication Notes

  1. Impact of unique host genetic variants in the HIV life cycle
    Human Gene (2025) — Differentiates HIV progression among South Indian females.
    Cited by: 5 articles

  2. Genomic Diversity and Antimicrobial Resistance of Acinetobacter sp.
    Indian Journal of Microbiology (2024) — Explores pan-genome and resistance markers.
    Cited by: 2 articles

  3. Association of Vitamin D receptor polymorphisms with Type 1 diabetes
    Journal of Clinical Research in Pediatric Endocrinology (2024) — Highlights VDR polymorphism link to T1D.
    Cited by: 3 articles

  4. The microbiome and rheumatic heart disease
    Acta Cardiologica (2023) — Discusses microbial links to RHD pathogenesis.
    Cited by: 1 article

  5. KIR-HLA ligand association with Type 1 Diabetes
    Immunological Investigations (2023) — Investigates KIR gene role in autoimmune risk.
    Cited by: 4 articles

  6. HLA-DRB1 Alleles with Rheumatic Heart Disease
    Immunological Investigations (2022) — Meta-analysis connecting HLA variants and RHD.
    Cited by: 6 articles

  7. HLA-G 3’UTR polymorphism and breast cancer
    Journal of Clinical Pathology (2020) — Links HLA-G variant with breast cancer susceptibility.
    Cited by: 12 articles